A Clinical Framework for Evaluating Cannabis Product Quality and Safety
Open Access
- 1 May 2023
- journal article
- research article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 8 (3) , 567-574
Abstract
Increase in medical cannabis use, along with available products, warrants the need for clinicians to be knowledgeable in evaluating the quality of any cannabis product presented in clinical practice. Determining whether a product is regulated within the region is key in assessing overall quality and safety. Regulated products are held to a higher standard including independent testing, contamination mitigation, and concentration limits. Here, we present a clinical framework in evaluating cannabis products to ascertain the quality and regulation level of the product. Evaluation includes assessing the source company, reviewing product details (e.g., type, cannabinoid content, and labeling), and assessing quality control variables such as manufacturing and decontamination processes. The quality of products patients use is an important part of mitigating cannabis-related harms, especially in medically vulnerable patients. Currently, there is a great need to implement widespread standardization and regulations to ensure product quality and safety.Keywords
This publication has 23 references indexed in Scilit:
- Multiresidue Method of Analysis of Pesticides in Medical CannabisJournal of AOAC INTERNATIONAL, 2018
- Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesisInternational Journal of Drug Policy, 2018
- Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and RecommendationsAmerican Journal of Public Health, 2017
- U.S. cannabis legalization and use of vaping and edible products among youthDrug and Alcohol Dependence, 2017
- Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington stateAddiction, 2017
- Current Therapeutic Cannabis Controversies and Clinical Trial Design IssuesFrontiers in Pharmacology, 2016
- Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal CannabisFrontiers in Pharmacology, 2016
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis ProductsJAMA, 2015
- A new method of cannabis ingestion: The dangers of dabs?Addictive Behaviors, 2014
- Inhaled medicinal cannabis and the immunocompromised patientSupportive Care in Cancer, 2014